Fairjourney Biologics, an established company with an outstanding track record of biotech, biopharmaceutical and Big pharma partners, offers a range of assets and services on antibody engineering, discovery, characterisation and production. Being one of the few profitable biotech companies, Fairjourney Biologics has implemented a co-development and R&D arm to complement its fee-for-service main unit. The company has developed a full suite of primers and has validated a naïve human library and a llama naïve library. Fairjourney Biologics has one of the biggest in the world antibody discovery teams available to partner. It has entered into agreements with academia, biotech companies and Big pharma to systematically explore ground breaking targets and creating new ventures. The unrivalled experience in llama, mice, rat, rabbit, chicken and human antibody discovery contributes to position the company in the forefront of antibody discovery, engineering, characterisation and production.